Page last updated: 2024-08-18

arginine vasopressin and conivaptan

arginine vasopressin has been researched along with conivaptan in 40 studies

Research

Studies (40)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (10.00)	18.2507
2000's	23 (57.50)	29.6817
2010's	12 (30.00)	24.3611
2020's	1 (2.50)	2.80

Authors

Authors	Studies
Ishii, N; Kusayama, T; Saito, M; Sugimoto, T; Tahara, A; Tanaka, A; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T	2
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Kusayama, T; Tahara, A; Takanashi, M; Tanaka, A; Tomura, Y; Tsukada, J; Uchida, W; Wada, KI; Yatsu, T	1
Ishii, N; Kusayama, T; Tahara, A; Tanaka, A; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T	1
Chanoine, F; Ghali, JK; Ghazzi, M; Hendrix, GH; Konstam, MA; Painchaud, CA; Pressler, ML; Selaru, P; Smith, WB; Thomas, I; Udelson, JE	1
Goldsmith, SR	1
Balding, LC; Burrell, LM; Johnston, CI; Naitoh, M; Risvanis, J	1
Thibonnier, M	1
Ishii, N; Kusayama, T; Shibasaki, M; Suzuki, T; Tahara, A; Taniguchi, N; Tomura, Y; Tsukada, J; Uchida, W; Wada, K; Yatsu, T	1
Golestaneh, L; Le Jemtel, TH; Talreja, A	1
Sanghi, P; Schwarz, ER	1
Brooks-Asplund, E; Fan, K; Ghali, JK; Koren, MJ; Long, WA; Smith, N; Taylor, JR	1
Streefkerk, JO; van Zwieten, PA	1
Pham, PC; Pham, PM; Pham, PT	1
Verbalis, JG	1
Arai, Y; Fujimori, A; Matsukawa, U; Miyata, K; Sasamata, M; Sudoh, K; Wada, K	1
Omland, T; Solberg, OG	1
Ali, F; Ghali, JK; Guglin, M; Vaitkevicius, P	1
Balk, RA; Patel, GP	1
Kumar, S; Mather, PJ; Rubin, S; Whellan, DJ	1
Haskal, R	1
Głuszek, J; Olszewski, W	1
Schweiger, TA; Zdanowicz, MM	1
Decaux, G; Soupart, A; Vassart, G	1
Farmakis, D; Filippatos, G; Gheorghiade, M; Kremastinos, DT	1
Boerrigter, G; Burnett, JC; Costello-Boerrigter, LC	1
Kumar, SK; Mather, PJ	1
Ghali, JK; Tam, SW	1
Carluccio, AL; Merlin, MA; Zenenberg, RD	1
Antrilli, TM; Campbell, BA; Crandall, DL; Crombie, AL; Failli, AA; He, Y; Kern, JC; Moore, WJ; Nogle, LM; Trybulski, EJ	1
Komai, Y; Palaniyandi, SS; Sukumaran, V; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K; Yamaguchi, K	1
Chiong, JR; Jao, GT	1
Cantillo, DS; Comín Colet, J; Robledo, GG	1
Fürstner, C; Gheorghiade, M; Kolkhof, P; Mondritzki, T; Sabbah, HN; Schaefer, S; Schmeck, C; Siedentop, H; Truebel, H	1
Caimi, G; Urso, C	1
Gai, L; Sun, Z; Xie, Y	1
Iwao, H; Izumi, Y; Miura, K	1
Fan, G; Han, J; Orgah, J; Wang, X; Yang, M; Zhang, B; Zhu, J; Zhu, Y	1
Avila-Blanco, ME; Calvillo-Robedo, A; González-Blas, D; Muñoz-Ortega, MH; Navarro-Gonzalez, YD; Quintanar-Stephano, A; Valdez-Urias, F; Ventura-Juarez, J	1

Reviews

25 review(s) available for arginine vasopressin and conivaptan

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Vasopressin receptor antagonists in heart failure. Current opinion in pharmacology, 2003, Volume: 3, Issue:6 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Pyrroles; Randomized Controlled Trials as Topic; Tolvaptan	2003
Vasopressin antagonists in heart failure. Current heart failure reports, 2004, Volume: 1, Issue:4 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Diuretics; Heart Failure; Humans; Randomized Controlled Trials as Topic; Tolvaptan; Water-Electrolyte Balance	2004
Conivaptan: a selective vasopressin antagonist for the treatment of heart failure. Expert review of cardiovascular therapy, 2006, Volume: 4, Issue:1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Heart Failure; Humans; Receptors, Vasopressin	2006
Vasopressin receptor antagonists: pharmacological tools and potential therapeutic agents. Autonomic & autacoid pharmacology, 2006, Volume: 26, Issue:2 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Drug Design; Heart Failure; Hormone Antagonists; Humans; Hypertension; Inappropriate ADH Syndrome; Indoles; Presynaptic Terminals; Pyrrolidines; Receptors, Vasopressin; Renal Artery; Sympathetic Nervous System; Synaptic Transmission; Tolvaptan; Vasoconstriction; Vasoconstrictor Agents	2006
Vasopressin excess and hyponatremia. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006, Volume: 47, Issue:5 Topics: Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Tolvaptan; Water-Electrolyte Balance	2006
AVP receptor antagonists as aquaretics: review and assessment of clinical data. Cleveland Clinic journal of medicine, 2006, Volume: 73 Suppl 3 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Tolvaptan; Water-Electrolyte Balance	2006
[Arginine vasopressin antagonism--new treatment option in chronic heart failure]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2007, Jan-18, Volume: 127, Issue:2 Topics: Animals; Antidiuretic Agents; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Nephrons; Prognosis; Pyrroles; Receptors, Vasopressin; Tolvaptan; Treatment Outcome; Vasoconstrictor Agents	2007
Therapeutic potential of vasopressin receptor antagonists. Drugs, 2007, Volume: 67, Issue:6 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan	2007
Recognition and treatment of hyponatremia in acutely ill hospitalized patients. Clinical therapeutics, 2007, Volume: 29, Issue:2 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Critical Illness; Humans; Hyponatremia; Inpatients; Practice Guidelines as Topic; Pyrroles; Randomized Controlled Trials as Topic; Tolvaptan	2007
Hyponatremia and vasopressin antagonism in congestive heart failure. Clinical cardiology, 2007, Volume: 30, Issue:11 Topics: Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Chronic Disease; Clinical Trials as Topic; Diuretics; Heart Failure; Humans; Hyponatremia; Models, Biological; Pyrroles; Registries; Renin-Angiotensin System; Sodium; Tolvaptan; Treatment Outcome; Vasopressins	2007
Current issues for nurse practitioners: Hyponatremia. Journal of the American Academy of Nurse Practitioners, 2007, Volume: 19, Issue:11 Topics: Aged; Algorithms; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Causality; Decision Trees; Diagnosis, Differential; Early Diagnosis; Female; Homeostasis; Humans; Hyponatremia; Nurse Practitioners; Nurse's Role; Nursing Assessment; Patient Selection; Primary Health Care; Pyrroles; Tolvaptan; Water-Electrolyte Balance	2007
[Vasopressin antagonists in treatment of hyponatremia]. Polskie Archiwum Medycyny Wewnetrznej, 2007, Volume: 117, Issue:8 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Sodium Chloride; Tolvaptan; Water-Electrolyte Balance	2007
Vasopressin-receptor antagonists in heart failure. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008, May-01, Volume: 65, Issue:9 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Cardiovascular Agents; Chronic Disease; Heart Failure; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Tolvaptan	2008
Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet (London, England), 2008, May-10, Volume: 371, Issue:9624 Topics: Animals; Antidiuretic Agents; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Contraindications; Humans; Hyponatremia; Models, Molecular; Receptors, Vasopressin	2008
Vasopressin and vasopressin antagonists in heart failure and hyponatremia. Current heart failure reports, 2008, Volume: 5, Issue:2 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Humans; Hyponatremia; Infusions, Intravenous; Male; Prognosis; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Risk Assessment; Survival Rate; Tolvaptan; Water-Electrolyte Imbalance	2008
Pharmacology of vasopressin antagonists. Heart failure reviews, 2009, Volume: 14, Issue:2 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Benzodiazepines; Heart Failure; Humans; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan	2009
AVP receptor antagonists in patients with CHF. Heart failure reviews, 2009, Volume: 14, Issue:2 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Sodium	2009
The critical link of hypervolemia and hyponatremia in heart failure and the potential role of arginine vasopressin antagonists. Journal of cardiac failure, 2010, Volume: 16, Issue:5 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Blood Pressure; Blood Volume; Female; Heart Failure; Humans; Hypertension; Hyponatremia; Male; Prevalence; Prognosis; Pyrroles; Receptors, Vasopressin; Tolvaptan; United States; Water-Electrolyte Balance	2010
Hyponatremia: evaluation and management. Hospital practice (1995), 2010, Volume: 38, Issue:1 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Urea Nitrogen; Cardiac Output, Low; Causality; Diagnosis, Differential; Glomerular Filtration Rate; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules; Saline Solution, Hypertonic; Sodium; Tolvaptan; Uric Acid; Water-Electrolyte Balance	2010
Arginine vasopressin receptor antagonists (vaptans): pharmacological tools and potential therapeutic agents. Drug discovery today, 2010, Volume: 15, Issue:19-20 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Drug Evaluation, Preclinical; Heart Failure; Humans; Hyponatremia; Receptors, Vasopressin; Sodium Potassium Chloride Symporter Inhibitors; Tolvaptan	2010
Hyponatremia in acute decompensated heart failure: mechanisms, prognosis, and treatment options. Clinical cardiology, 2010, Volume: 33, Issue:11 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Biomarkers; Fluid Therapy; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Receptors, Vasopressin; Renin-Angiotensin System; Sodium; Tolvaptan; Treatment Outcome; Ventricular Dysfunction	2010
[Hyponatremia in heart failure: physiopathology and pharmacological approach]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2010, Volume: 57 Suppl 2 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Brain Edema; Demyelinating Diseases; Diuresis; Diuretics; Double-Blind Method; Heart Failure; Humans; Hyponatremia; Kidney; Multicenter Studies as Topic; Natriuresis; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Renin-Angiotensin System; Saline Solution, Hypertonic; Sympathetic Nervous System; Tolvaptan	2010
[Hyponatremic syndrome]. La Clinica terapeutica, 2012, Volume: 163, Issue:1 Topics: Aging; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Brain; Brain Edema; Exercise; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infections; Inflammation; Kidney; Natriuresis; Neoplasms; Osmotic Pressure; Renal Replacement Therapy; Sodium; Tolvaptan; Water Intoxication	2012
Therapeutic potential of vasopressin-receptor antagonists in heart failure. Journal of pharmacological sciences, 2014, Volume: 124, Issue:1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Clinical Trials as Topic; Disease Models, Animal; Heart Failure; Homeostasis; Humans; Hyponatremia; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan; Ventricular Remodeling	2014

Trials

2 trial(s) available for arginine vasopressin and conivaptan

Article	Year
Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure. Circulation, 2001, Nov-13, Volume: 104, Issue:20 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Double-Blind Method; Electrolytes; Female; Heart Failure; Hemodynamics; Humans; Kidney; Kinetics; Male; Middle Aged; Osmolar Concentration; Pulmonary Wedge Pressure; Urine	2001
Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia. The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:6 Topics: Administration, Oral; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Double-Blind Method; Female; Humans; Hyponatremia; Male; Sodium	2006

Article

Year

Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure.

Circulation, 2001, Nov-13, Volume: 104, Issue:20

Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Double-Blind Method; Electrolytes; Female; Heart Failure; Hemodynamics; Humans; Kidney; Kinetics; Male; Middle Aged; Osmolar Concentration; Pulmonary Wedge Pressure; Urine

2001

Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia.

The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:6

Topics: Administration, Oral; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Double-Blind Method; Female; Humans; Hyponatremia; Male; Sodium

2006

Other Studies

13 other study(ies) available for arginine vasopressin and conivaptan

Article	Year
Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist. Naunyn-Schmiedeberg's archives of pharmacology, 1998, Volume: 357, Issue:1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Binding, Competitive; Calcium; Cloning, Molecular; COS Cells; Cyclic AMP; Dose-Response Relationship, Drug; Hemostatics; Humans; Radioligand Assay; Receptors, Vasopressin; Regression Analysis; Renal Agents; Transfection	1998
Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells. British journal of pharmacology, 1998, Volume: 125, Issue:7 Topics: Animals; Benzazepines; Binding, Competitive; Calcium; CHO Cells; Cricetinae; Cyclic AMP; Humans; Indoles; Morpholines; Piperidines; Pyrrolidines; Quinolones; Receptors, Vasopressin; Spiro Compounds; Transfection; Tritium	1998
Pharmacological profile of YM087, a novel potent nonpeptide vasopressin V1A and V2 receptor antagonist, in vitro and in vivo. The Journal of pharmacology and experimental therapeutics, 1997, Volume: 282, Issue:1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium; Cyclic AMP; Female; In Vitro Techniques; Male; Radioligand Assay; Rats; Rats, Wistar	1997
Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte. Cardiovascular research, 1998, Volume: 38, Issue:1 Topics: Analysis of Variance; Animals; Animals, Newborn; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Leucine; Myocardium; Piperidines; Protein Biosynthesis; Quinolones; Rats; Rats, Wistar; Receptors, Vasopressin; Stimulation, Chemical; Thymidine	1998
Vasopressin antagonists in CHF: ready for clinical trials? Cardiovascular research, 2002, Volume: 54, Issue:1 Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Heart Failure; Humans	2002
Neurohormonal antagonism in heart failure; beneficial effects of vasopressin V(1a) and V(2) receptor blockade and ACE inhibition. Cardiovascular research, 2002, Volume: 54, Issue:1 Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Captopril; Female; Heart Failure; Myocardium; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Renin	2002
Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptors. Pharmacological research, 2005, Volume: 51, Issue:3 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Female; Humans; Piperidines; Protein Binding; Receptors, Oxytocin; Receptors, Vasopressin; Second Messenger Systems; Vasopressins	2005
A novel vasopressin dual V1A/V2 receptor antagonist, conivaptan hydrochloride, improves hyponatremia in rats with syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Biological & pharmaceutical bulletin, 2007, Volume: 30, Issue:1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Disease Models, Animal; Diuretics; Dose-Response Relationship, Drug; Furosemide; Hyponatremia; Inappropriate ADH Syndrome; Injections, Intravenous; Male; Osmolar Concentration; Potassium; Rats; Rats, Wistar; Sodium; Water; Water-Electrolyte Balance	2007
Synthesis and evaluation of azabicyclo[3.2.1]octane derivatives as potent mixed vasopressin antagonists. Bioorganic & medicinal chemistry letters, 2010, Jun-15, Volume: 20, Issue:12 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Aza Compounds; Benzazepines; Bridged Bicyclo Compounds; Humans; Molecular Structure; Octanes; Structure-Activity Relationship	2010
Differentiation of arginine vasopressin antagonistic effects by selective V2 versus dual V2/V1a receptor blockade in a preclinical heart failure model. American journal of therapeutics, 2011, Volume: 18, Issue:1 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Cardiac Output; Cardiac Pacing, Artificial; Dogs; Heart Failure; Hemodynamics; Pacemaker, Artificial; Tolvaptan; Urodynamics; Vascular Resistance	2011
[Conivaptan inhibites cell proliferation and collagen production of cardiac fibroblasts induced by arginine vasopressin]. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2013, Volume: 29, Issue:5 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Cell Proliferation; Collagen; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type III; Myofibroblasts; Rats; RNA, Messenger	2013
Danhong injection attenuates cardiac injury induced by ischemic and reperfused neuronal cells through regulating arginine vasopressin expression and secretion. Brain research, 2016, 07-01, Volume: 1642 Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Cardiovascular Agents; Cell Hypoxia; Cell Survival; Cells, Cultured; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Glucose; Mitochondria; Myocytes, Cardiac; Neurons; Neuroprotective Agents; Rats, Wistar; Receptors, Vasopressin	2016
Arginine vasopressin deficiency and conivaptan (a V1a-V2 receptor antagonist) treatment reverses liver damage and fibrosis in rats with chronic portocaval anastomosis. International journal of experimental pathology, 2023, Volume: 104, Issue:4 Topics: Anastomosis, Surgical; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine; Arginine Vasopressin; Cricetinae; Diabetes Insipidus, Neurogenic; Liver Cirrhosis; Rats; Receptors, Vasopressin	2023